Skip to main content
. 2012 Jun 7;15(3):330–341. doi: 10.1007/s11102-012-0397-5

Fig. 5.

Fig. 5

Mean change from baseline to week 24/ET in glycemic parameters (AUCglucose and plasma and fasting plasma glucose as measured by 2-h OGTT, and HbA1c) among patients treated with mifepristone. Bars indicate SD (AUC, area under the curve; C-DM, Cushing's with diabetes mellitus or hyperglycemia; OGTT, oral glucose tolerance test; ET, early termination) [67] (adapted from Fleseriu M, et al. J Clin Endocrinol Metab 2012. Copyright 2012, The Endocrine Society)